These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 2126721)

  • 1. [The intracardial hemopump. A new technique of left ventricle assist device].
    Loisance D; Dubois-Randé JL; Deleuze P; Rosenval O; Zelinski R; Shiiya N; Geschwind H
    Arch Mal Coeur Vaiss; 1990 Dec; 83(14):2129-34. PubMed ID: 2126721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [High-risk PTCA assisted by the Hemopump 14F: the Geneva experience].
    Panos A; Kalangos A; Urban P
    Schweiz Med Wochenschr; 1999 Oct; 129(42):1529-34. PubMed ID: 10568235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTCA with the use of cardiac assist devices: risk stratification, short- and long-term results.
    Ferrari M; Scholz KH; Figulla HR
    Cathet Cardiovasc Diagn; 1996 Jul; 38(3):242-8. PubMed ID: 8804779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M
    Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience.
    Rajdev S; Krishnan P; Irani A; Kim MC; Moreno PR; Sharma SK; Kini AS
    J Invasive Cardiol; 2008 Feb; 20(2):67-72. PubMed ID: 18252970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.
    Aragon J; Lee MS; Kar S; Makkar RR
    Catheter Cardiovasc Interv; 2005 Jul; 65(3):346-52. PubMed ID: 15945107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the hemopump left ventricular assist device on regional myocardial perfusion and function. Reduction of ischemia during coronary occlusion.
    Merhige ME; Smalling RW; Cassidy D; Barrett R; Wise G; Short J; Wampler RK
    Circulation; 1989 Nov; 80(5 Pt 2):III158-66. PubMed ID: 2805297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporary circulatory assist during high-risk coronary angioplasty. Which technique for which patients?
    Haendchen RV; Corday E
    Arq Bras Cardiol; 1991 May; 56(5):341-8. PubMed ID: 1823730
    [No Abstract]   [Full Text] [Related]  

  • 10. The evolving role for a left ventricular assist device in high-risk percutaneous coronary interventions.
    Hopkins J; Weintraub W
    J Invasive Cardiol; 2006 Mar; 18(3):97-8. PubMed ID: 16598105
    [No Abstract]   [Full Text] [Related]  

  • 11. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
    Vranckx P; Schultz CJ; Valgimigli M; Eindhoven JA; Kappetein AP; Regar ES; Van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):302-10. PubMed ID: 19360865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance.
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    J Am Coll Cardiol; 1996 Nov; 28(5):1119-26. PubMed ID: 8890804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support.
    Branch KR; Dembitsky WP; Peterson KL; Adamson R; Gordon JB; Smith SC; Jaski BE
    J Heart Lung Transplant; 1994; 13(4):641-50; discussion 651. PubMed ID: 7947881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics.
    Remmelink M; Sjauw KD; Henriques JP; de Winter RJ; Koch KT; van der Schaaf RJ; Vis MM; Tijssen JG; Piek JJ; Baan J
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):532-7. PubMed ID: 17896398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk percutaneous coronary intervention using the intracardiac microaxial pump 'Impella recover'.
    Ramondo A; Napodano M; Tarantini G; Calzolari D; Nalli C; Cacciavillani L; Iliceto S
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):149-52. PubMed ID: 16645377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5.
    Henriques JP; Remmelink M; Baan J; van der Schaaf RJ; Vis MM; Koch KT; Scholten EW; de Mol BA; Tijssen JG; Piek JJ; de Winter RJ
    Am J Cardiol; 2006 Apr; 97(7):990-2. PubMed ID: 16563902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of action.
    Vijayalakshmi K; Kunadian B; Whittaker VJ; Wright RA; Hall JA; Sutton A; Muir D; de Belder MA
    J Invasive Cardiol; 2007 Aug; 19(8):339-46. PubMed ID: 17712202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.